Publication date: Feb 10, 2021
GRACE is excited to bring you a new series on current updates in Melanoma Treatment. Meredith McKean MD, MPH with Tennessee Oncology, Michael Postow, MD Chief of Melanoma Service at Memorial Sloan Kettering, and Sanjiv Agarwala, MD, Professor of Medical Oncology and Hematology at Temple University School of Medicine in Easton, PA joined GRACE to discuss current updates in treatment for Melanoma. In this video, Dr. Postow discusses understanding immunotherapy resistance mechanisms in melanoma. A huge thank you to Merck for sponsoring this program. For more, please visit http://cancerGRACE. org/. To join the conversation, visit https://cancergrace. org/forum.
|pathway||KEGG||Antigen processing and presentation|